Author(s):
Mrityunjoy Majumdar, Nilendu Sekhar Sarkar, Debapriya Das, Arnab Samanta, Sourav Roy, Prodip Roy, Soumyadeb Dutta
Email(s):
prodiproy19951228@gmail.com
DOI:
10.52711/0974-360X.2024.00911 
Address:
Mrityunjoy Majumdar1, Nilendu Sekhar Sarkar2, Debapriya Das1, Arnab Samanta3, Sourav Roy1, Prodip Roy1*, Soumyadeb Dutta1
1Department of Pharmacology, Netaji Subhas Chandra Bose Institute of Pharmacy, Chakdaha, Nadia, West Bengal, India – 741222.
2Indoriv Clinical Private Limited, 87, Chowringhee Road, Kolkata 700020, West Bengal, India.
3Department of Pharmaceutics, Netaji Subhas Chandra Bose Institute of Pharmacy, Chakdaha, Nadia, West Bengal, India – 741222.
*Corresponding Author
Published In:
Volume - 17,
Issue - 12,
Year - 2024
ABSTRACT:
Ending a pregnancy is quite common these days. In developing countries, there are much more cases termed as unsafe abortion. Some standard drugs are already available in the market, most of them are possessing high level of toxicity and expensive. There is always search for a new drug which is safe and cost effective. Ageratina adenophora is a medicinal plant in the Asteraceae family. It mainly contains alkaloids. In this experiment, the study was focused on evaluating the abortifacient effect of Ageratina adenophora. The hydroalcoholic extract of the pods of Ageratina adenophora was formed by the maceration process. The extract has shown a promising effect as an abortion-inducing agent while compared with the standard drugs. The animals treated with the extract of Ageratina adenophorahas decreased the abortion time within 15.01 hrs with 85.22 percent fatality in offspring which is noteworthy. The research outcomes indicate that the hydroalcoholic extract of the pods of the Ageratina adenophora has shown significant abortifacient activity.
Cite this article:
Mrityunjoy Majumdar, Nilendu Sekhar Sarkar, Debapriya Das, Arnab Samanta, Sourav Roy, Prodip Roy, Soumyadeb Dutta. Preclinical evaluation of pods of Ageratina adenophora for its rudimentary fatal activity. Research Journal Pharmacy and Technology. 2024;17(12):6003-7. doi: 10.52711/0974-360X.2024.00911
Cite(Electronic):
Mrityunjoy Majumdar, Nilendu Sekhar Sarkar, Debapriya Das, Arnab Samanta, Sourav Roy, Prodip Roy, Soumyadeb Dutta. Preclinical evaluation of pods of Ageratina adenophora for its rudimentary fatal activity. Research Journal Pharmacy and Technology. 2024;17(12):6003-7. doi: 10.52711/0974-360X.2024.00911 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-12-48
REFERENCE:
1. Engelstadter J. Constraints on the evolution of asexual reproduction. Bio Essays. 2008; 30(11‐12): 1138-50. doi.org/10.1002/bies.20833
2. Wassarman PM. The biology and chemistry of fertilization. Science. 1987; 235(4788): 553-560. doi.org/10.1126/science.3027891
3. Chinchpure S. A Comparative Study to Assess Relationship of Placental Weight in Normal Pregnant Women and in Anemic Pregnant Women in Selected Hospital of Pune City. Asian Journal of Nursing Education and Research. 2014; 4(3): 307-313.
4. Saha A, et al. Herbal Agents Having Abortive Activity. Journal for Research in Applied Sciences and Biotechnology. 2022; Aug 31; 1(3): 204-15. doi.org/10.55544/jrasb.1.3.27
5. Costescu D, et al. Medical abortion. Journal of Obstetrics and Gynaecology Canada. 2016; 38(4): 366-89. doi.org/10.1016/j.jogc.2016.01.002
6. Christin-Maitre S, et al. Medical termination of pregnancy. New England Journal of Medicine. 2000; 342(13): 946-56. doi.org/10.1056/NEJM200003303421307
7. Pincus G, MC C. The effects of progesterone and related compounds on ovulation and early development in the rabbit. ActaPhysiologica Latino Americana. 1953; 3(2-3): 177-83.
8. Rock J, et al. Effects of certain 19-nor steroids on the normal human menstrual cycle. Science. 1956; 124(3227): 891-3. doi.org/10.1126/science.124.3227.891
9. Shep SG, et al. A Novel Method for Female Contraception: A Review. Research Journal of Pharmacy and Technology. 2010; 3(2): 339-43.
10. Aitken RJ, et al. As the world grows: contraception in the 21st century. The Journal of clinical investigation. 2008;118(4): 1330-43. doi.org/10.1172/JCI33873
11. Devi LD, Mariamma TL. Effectiveness of Structured Teaching Programme in terms of Knowledge regarding Medical Termination of Pregnancy among Reproductive age group women in a selected Urban Slum area, Bangalore. International Journal of Advances in Nursing Management. 2020; 8(1): 19-22. doi.org/10.5958/2454-2652.2020.00006.2
12. Singh S, et al. Herbal options in pregnancy: A review. Research Journal of Science and Technology. 2011; 3(3): 127-8.
13. Fiala C, Danielsson KG. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006; 74(1): 66-86. doi.org/10.1016/j.contraception.2006.03.018
14. Devadasu CH, et al. A Spectrophotometric Assay for the Simultaneous Analysis of Mifepristone and Misoprostol in Tablets Using Vierodt's and Absorbance Ratio Methods. Research Journal of Pharmacy and Technology. 2012; 5(1): 46-9.
15. Jackson E, Kapp N. Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review. Contraception. 2011; 83(2): 116-26. doi.org/10.1016/j.contraception.2010.07.014
16. Selvi KV, et al. Analysis of bioactive metabolites from azollapinnata against dental caries. Research Journal of Pharmacy and Technology. 2017; 10(6): 1891-6. doi.org/10.5958/0974-360X.2017.00332.8
17. Preethi PJ, et al. Rising trends towards natural contraception: A Review. Asian Journal of Research in Pharmaceutical Science. 2014; 4(3): 130-4.
18. Shivarkar R, et al. Formulation and Evaluation of Curcuma longa and Azadirachtaindica Extracts as Vaginal Contraceptive. Research Journal of Pharmacology and Pharmacodynamics. 2012; 4(1): 21-4.
19. Tripathi K. A review: herbal abortifacients. Asian Journal of Research in Chemistry. 2009; 2(3): 239-45.
20. Kavya R, et al. Studies on the anti-fertility efficacy of Abrime and Embrelin, the compounds of plant origin on mouse testis and uterus. Research Journal of Pharmacy and Technology. 2015; 8(4): 369-75. doi.org/10.5958/0974-360X.2015.00062.1
21. Kadibagil VR, Sarashetti RS. Experimental evaluation of Pippali, Vidanga and Tankana for contraceptive effect. Research Journal of Pharmacy and Technology. 2023; 16(7): 3099-103. doi.org/10.52711/0974-360X.2023.00509
22. Indalkar YR, et al. A compressive review on the study of nanotechnology for herbal drugs. Asian Journal of Pharmaceutical Research. 2015; 5(4): 203-7. doi.org/10.5958/2231-5691.2015.00031.3
23. Fiala C, et al. Management of pain associated with up-to-9-weeks medical termination of pregnancy (MToP) using mifepristone–misoprostol regimens: expert consensus based on a systematic literature review. Journal of Obstetrics and Gynaecology. 2020; 40(5): 591-601. doi.org/10.1080/01443615.2019.1634027.
24. MajumdarM,et al. Preclinical Evaluation of hydroalcoholic extract of Moringaoleifera leaves for its Cardiotropic activity on albino Wistar rat. Research Journal of Pharmacy and Technology. 2023; 16(7): 3417-21. doi.org/10.52711/0974-360X.2023.00565
25. Kokate CK, Purohit AP, Gokhale SB. Book of Pharmacognosy. Niraliprakashan 36th edition. 2005.
26. Saha S, et al. Preclinical evaluation of hydro alcoholic extract of fruits of cascabelathevetia for its cardio toxic activity. Research Journal of Pharmacy and Technology. 2019; 12(8): 3755-8.doi.org/10.5958/0974-360X.2019.00643.7
27. SamadderSS,et al. Preclinical Evaluation of Tropic Activity on Isolated Frog Heart by Using Volatile Oil of Nigella sativa Seeds. Journal for Research in Applied Sciences and Biotechnology. 2022; 1(4): 1-4. doi.org/10.55544/jrasb.1.4.1